Commentary · 17 Jun 2025
Conference abstractPublished 17 Sep 2020
Tamoxifen Protects from Vesicular Stomatitis Virus Infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Tamoxifen (TAM) is an estrogen-receptor antagonist, widely used in the adjuvant treatment of early stage estrogen-sensitive breast cancer. Several studies have revealed new biological targets of TAM that mediate the estrogen receptor independent activities of the drug. Recently, the antiviral activity of TAM on replication of human immunodeficiency virus (HIV), hepatitis C virus (HCV) and Herpes simplex virus (HSV-1) in vitro was described. In the current study, we aimed to investigate the effect of TAM
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Applied Microbiology and Biochemistry.
Commentary · 17 Jun 2025
Chlamydia muridarum and Tubal Factor Infertility: Mechanisms and Models
Commentary · 17 Jun 2025
Iron Acquisition Mechanisms in Klebsiella pneumoniae: A Virulence Strategy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Applied Microbiology and Biochemistry
- SubjectBiochemistry & Biotechnology
- SubjectMicrobiology
- BylineArticles whose byline prints “Lamin B. Cham”
